STAT+: FTC files lawsuit to block Amgen’s purchase of Horizon Therapeutics

The FTC sued to block Amgen’s $27.8 billion acquisition of Horizon Therapeutics, signaling possible tougher scrutiny of biopharma takeovers even as the pace of deals starts to mount a comeback.